Preparing for the Next Pandemic
WuXi Vaccines offers a CDMO's perspective on meeting the global vaccine supply challenge.
Stay updated with breaking news from Process Performance Qualification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WuXi Vaccines offers a CDMO's perspective on meeting the global vaccine supply challenge.
WuXi Vaccines offers a CDMO's perspective on meeting the global vaccine supply challenge.
Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.
GenSight Biologics pushed back regulatory dates because of an operational issue at CDMO Brammer Bio, a subsidiary of Thermo Fisher.
PPQ campaign to start early May 2023 (previously end of March) with results expected in Q3 2023 EMA CHMP opinion now expected in Q1 2024 (previously September 2023) Regulatory News: GenSight